Introductie

Longarts in Medisch Spectrum Twente: locatie Enschede en Oldenzaal.
Speciale aandachtsgebieden:

• Longkanker
• Borstvlieskanker (asbest gerelateerd)
• Longchirurgie

Opleiding

Publicaties

Proefschrift

“Photodynamic Therapy for Malignant Pleural Mesothelioma“

Promotie: 27 maart 1992

Promotor: Prof. Dr. S. Rodenhuis, Amsterdam

Schouwink JH, Nortier J.W.R. Voor- en nadelen van erytropoëtine bij patiënten met kanker. Oncollectie 4-2008.

Schouwink JH, Codrington H, Sleeboom HP, Kerkhofs LG, Worwmhoudt LW.

Prevention of anaemia by early intervention with once weekly epoietin alfa during chemotherapy. Eur J Cancer 2008; April 44 (6): 819-29.

Baas P, Sleeswijk P, Strankinga WF, van Hezik EJ, Burgers JA, Tan KY, Schouwink JH.

Problematic cases of mesothelioma reported to the Dutch Institute for Asbestos Victims: evaluation by the Mesothelioma Working Group of the Netherlands Association of Pulmunologists and Specialists in Tuberculosis. Ned Tijdschr Geneesk 2005; April 149: 759-63.

Schouwink H, Baas P.

Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma. Ann Thorac Surg 2004; July 78: 388.

Plaisier PW, Mulder HJ, Schouwink JH, de Smit P.

Cervical mediastinoscopy in The Netherlands: past or present? A retrospective analysis of 218 cases. Neth J Med 2003; August 61: 253-6.

Schouwink JH, Kool LS, Rutgers EJ, Zoetmulder FA, van Zandwijk N, v.d.Vijver MJ, Baas P.

The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thor Surg 2003; June 75: 1715-8.

Schouwink H, Oppelaar H, Ruevekamp M, vd Valk M, Hart G, Rijken P, Baas P, Stewart FA.

Oxygen depeltion during and after mTHPC-mediated photodynamic therapy in RIF1 and H-MESO1 tumors. Radiat Res 2003 February 159: 190-8.

V Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, v Klaveren RJ, de Jonge MJ, van Meerbeeck JP.

Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer 2002; February 86: 342-5.

Schouwink H, Rutgers ET, van der Sijp J. Oppelaar H, van Zandwijk N, van Veen R, Burgers S, Stewart FA, Zoetmulder F, Baas P.

Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose-finding and toxicity results. Chest 2001; October 120:1167-74.

Van Veen R, Schouwink JH, Star WM, Sterenborg HJ, van der Sijp JR, Stewart FA, Baas P.

Wedge-shaped applicator for additional light delivery and dosimetry in the diaphragmal sinus during photodynamic therapy for malignant pleural mesothelioma. Phys Med Biol 2001; July 46: 1873-83.

Schouwink H, Ruevekamp M, Oppelaar H, van veen R, Baas P, Stewart FA.

Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols. Photochem Photobiol 2001; April 73: 410-7.

Baas P, van Meerbeeck J, Groen H, Schouwink H, Burgers S, Daamen S, Giaccone G. Carlyx in malignant mesothelioma. Ann Oncol 2000; June 11: 697-700.

Klaase JM, Swaanenburg JC, Schouwink H, Sosef MN, Bonfrer JM, Zoetmulder FA, Rutgers EJ,

Baas P. Monitoring of imepending myocardial damage after pleuropneumoectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.

Photochem Photobiol 2000; Mar 71: 351-4.

Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P. Prognostic value of the serum tumourmarkers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma. Lung Cancer 1999 July 25: 25-32.

Schouwink H, Baas P, Rutgers ET, Zoetmulder FA. Malignant pleural mesothelioma. Eur Respir J 1999; Mar 13: 706.

Schouwink JH, Toben FM, Wagenaar SS. Diagnostic examination for causes of exudative pleurisy. Ned Tijdschr Geneesk 1998; Nov 21: 2553-6.

Baas P, Schouwink H, Zoetmulder FA. Malignant pleural mesothelioma. Ann Oncol 1999; Feb 9: 139-49.

Belderbos JS, Aleman BM, Boersma LJ, Schouwink JH, Bartelink H. Pleural mesothelioma in family practice: complicated pain problems. Ned Tijdschr Geneesk 1997; Aug 141: 1582.

Bonfrer JM, Schouwink JH, Korse CM, Baas P. Cyfra 21-1 and TPA as markers in malignant mesothelioma. Anticancer Res. 1997; Jul-Aug 17: 2961-3.

Schouwink JH, Weigel HM, Blaauwgeers JL, Schreurs AJ. Aspergilloma formation in a pneumatocele associated with Pneumocystis carinii pneumonia. AIDS 1997; Jan 11: 135-7.